Liberate Medical Breathes Easy with $6.2M Series B Funding Boost

Key Takeaways:

• Liberate Medical raises $6.2 million in Series B funding led by Scientific Health Development Partners.
• The Crestwood, Kentucky-based startup has developed a unique technology synchronized with patients’ breathing cycles.
• The new injection of capital takes the startup’s total funding to over $10 million, across 11 funding rounds.
• The raised funds will further propel Liberate Medical’s growth in the biotechnology, health care, and medical devices industries.

Medical tech startup, Liberate Medical, has successfully secured $6.2 million in its recent Series B funding round. The round, spearheaded by Scientific Health Development Partners, underpins a strong vote of confidence in the startup’s groundbreaking technology, which operates in sync with patients’ breathing cycles.

This financing round, finalized on July 5, 2023, represents the latest cash injection into the rapidly advancing biotech firm. With this latest investment, the total capital amassed by Liberate Medical has now surpassed the $10 million mark, across an impressive 11 rounds of funding.

Liberate Medical, headquartered in Crestwood, Kentucky, is making strides in the biotechnology, health care, and medical devices industries. Their unique technology that aligns with a patient’s breathing cycle represents a significant innovation in medical treatment methods.

Founded on a patient-centric philosophy, the company is steadfastly dedicated to enhancing the quality of life for patients worldwide. The recent funding will fuel their mission by affording opportunities to accelerate research and development, expand its innovative product portfolio, and extend its market reach.

To learn more about Liberate Medical and stay updated on its journey, check out their Crunchbase profile.

This new investment from Scientific Health Development Partners validates the potential of Liberate Medical’s unique approach to patient care. By aligning technology with the natural rhythms of the human body, the company is pushing boundaries and setting new standards in the medical industry.

The future certainly looks promising for Liberate Medical, and the healthcare landscape, thanks to this revolutionary innovation. One can expect the $6.2 million funding to invigorate the startup, spurring on both product development and market expansion efforts.

This is certainly a company to watch as it continues to make waves in the healthcare, medical, and biotech sectors, improving lives one breath at a time.

Ready to amplify your reach and engage with the most dynamic community in the venture world? Consider sponsoring an article with us. Learn more about our promotional opportunities and sponsored articles here.

Your story could be the next big hit on US Venture News!